CA-PATIENT-SAFETY-MVMT
The Patient Safety Movement Foundation (PSMF) , a global non-profit committed to achieving zero preventable patient harm and death across the globe by 2030, has selected five individuals for its inaugural Patient Safety Movement Foundation Healthcare Safety Fellowship program. The 12-month, part-time program is focused on providing education and continued development of skills for future healthcare leaders – positioning these stand-out individuals to serve as regional and global leaders in patient safety improvement for years to come.
“We are excited to launch our fellowship program and provide an opportunity to unify and prepare future leaders in patient safety,” said David B. Mayer, MD, CEO of the Patient Safety Movement Foundation. “These individuals have already demonstrated a commitment to improving healthcare, and we look forward to helping them design an individualized education plan that furthers their efforts and collectively helps us in our goal to achieve zero preventable patient deaths by 2030.”
Each of the five fellows will receive guidance from PSMF in designing an actionable plan that is tailored to their background, goals and the specific health needs of their region. In addition, fellows will have opportunities to interact and collaborate with an international network of patient safety and quality mentors, as well as facilitate and lead clinical coaching efforts with hospitals and healthcare organizations across the globe.
This year’s cohort participants include:
-
Luis Ramón Torres Torija Arguelles, MD, MBA
Dr. Luis Torres Torija Arguelles is a physician with a specialty in quality of clinical care from the Tecnológico de Monterrey in Mexico. He currently works as a quality and patient safety coordinator at Hospital Español in Mexico City, Mexico, where he is responsible for the management, design, evaluation, improvement and innovation of clinical care and patient safety processes, incorporating methodologies for continuous improvement and better communication. His efforts to implement all the Patient Safety Movement Foundation’s Actional Patient Safety Solutions have earned his hospital the 5-star Hospital recognition.
-
Carol Gunn, MD
Dr. Carol Gunn attended medical school at UC Davis and completed her internal medicine residency in Portland, Ore., followed by an additional year of training in occupational and environmental medicine at the University of Colorado. In 2007, she opened an independent occupational medicine practice. She thrives on working with individuals and groups advocating for system solutions – whether it be for health, wellness or patient safety.
-
Samar Hassan, PH, MSQ, CPHQ, FISQua
Samar Hassan holds a master’s degree in healthcare quality management and is a registered pharmacist and certified healthcare quality professional with the National Association for Healthcare Quality (NAHQ). In addition, Hassan has worked with the Health Care Accreditation Council (HCAC) in Jordan and the region’s quality improvement and patient safety institution since 2018, where she has been involved in the design, implementation and evaluation of standards for quality and patient safety across health and social care institutions. She has also participated and supported HCAC's advocacy and public awareness programs to synthesize professionals, the public and decision makers on adopting and implementing quality improvement approaches.
-
Elizabeth Namugaya Igaga, MD
Dr. Elizabeth Namugaya Igaga attended Makerere University in Kampala, Uganda, for medical school, as well as her master’s degree in anesthesia and critical care. She is currently doing her clinical practice at the Uganda Heart Institute. Igaga’s interest in patient safety was sparked after multiple firsthand experiences during residency that resulted in near misses or catastrophic outcomes. Since then, she has been passionate about fostering and building a culture of safety in perioperative care in Uganda.
-
Ebikapaye Okoyen, MD, MBBS, MBA, MHPM, FISQua
Dr. Ebikapaye Okoyen works in the Ministry of Health in Yenagoa, Nigeria, as the deputy director and state program manager for Saving One Million Lives Program for Results (SOML PforR) – a World Bank-funded, results-based program financing maternal and child health and nutrition aimed at improving quantity and quality of service. He is a fellow and member of several professional associations including the Nigerian Medical Association, the Society for Quality in Healthcare in Nigeria (SQHN) and is a certified SQHN Health Facility Surveyor with a specialist certificate on the Fundamentals of External Evaluation Surveying from the International Society for Quality in Healthcare (ISQua). He has also published papers in health services research.
To learn more about the Patient Safety Movement Foundation Healthcare Safety Fellowship, visit: https://patient.sm/PR-Fellowship .
About the Patient Safety Movement Foundation: Each year, more than 200,000 people die unnecessarily in U.S. hospitals, with more than three million deaths globally, as a result of unsafe care. The Patient Safety Movement Foundation (PSMF) is a global non-profit with a vision to eliminate preventable patient harm and death across the globe by 2030. PSMF unites patients, advocates, healthcare providers, medical technology companies, government, employers and private payers in support of this cause. From its Actionable Patient Safety Solutions and industry Open Data Pledge to its World Patient Safety, Science & Technology Summit and more, PSMF won’t stop fighting until it achieves zero preventable patient harm and death. For more information, please visit patientsafetymovement.org , and follow PSMF on LinkedIn , Twitter , Instagram and Facebook .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210512005327/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical Group Enters the Thai Market through Partnership with BLEZ14.11.2025 13:47:00 CET | Press release
-- Advancing Its Overseas Growth Strategy to Expand Japanese-Quality Aesthetic Medicine Across Asia Following Singapore -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that it has entered into a Consulting Agreement with BLEZ ASIA Co., Ltd. (Headquarters: Bangkok, Thailand; CEO: Naoki Iida; “BLEZ”), which operates more than 20 pharmacies and clinics in Thailand and is widely trusted by both Japanese expatriates and local patients. The partnership is a key component of SBC’s broader Asia strategy and represents a significant step toward full-scale entry into the rapidly growing Thai aesthetic medicine market. Under the agreement, SBC will provide comprehensive management support to a new clinic focused primarily on dermatological treatments such as pigmentation and spot removal, which BLEZ is preparing to open in
SBC Medical Group Holdings Announces Third Quarter 2025 Financial Results14.11.2025 13:00:00 CET | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced its financial results for the third quarter of fiscal year 2025 (three months ended September 30, 2025) and for the third quarter cumulative of fiscal year 2025 (Year-to-Date 2025, nine months ended September 30, 2025) Third Quarter 2025 Highlights Total revenues were $43 million, representing an 18% year-over-year decrease. Income from operations was $16 million, representing a 15% year-over-year increase. Net Income attributable to SBC Medical Group was $13 million , representing an 353% year-over-year increase. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.12 for the three months ended September 30, 2025, compared to $0.03 in the same period of 2024. EBITDA1, which
Ant Group Chairman Eric Jing Outlines Strategy for Inclusive AI, Collaboration on Tokenised Settlement14.11.2025 11:15:00 CET | Press release
AI-as-a-Service applications will make AI virtual CFO and COO for SMEsPublic-private collaboration in regulatory sandboxes help to provide clarity and certainty when it comes to new technology like tokenisation and AI Eric Jing, Chairman of Ant Group, said the company's focus is on putting new payment and operation tools powered by AI and tokenisation technology in the hands of SMEs, to fully embrace the next wave of global productivity revolution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251114239737/en/ Ant Group Chairman Eric Jing (second from right) shares insights during a panel discussion titled “Steering the Global Future” during the Singapore FinTech Festival on November 14, 2025. “We are passionate about using frontier technology to support SMEs and the use of AI will really uplift inclusion,” Jing said during a panel discussion titled “Steering the Global Future” during the Singapore FinTech Festival on Novem
Allianz Achieves Record Results and Expects a Full-Year Operating Profit of at Least 17 Billion Euros14.11.2025 07:16:00 CET | Press release
3Q 2025 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251113803211/en/ Oliver Bäte, Chief Executive Officer of Allianz SE Double-digit growth in operating profit and shareholders’ core net incomeTotal business volume rises 5.21 percent with contributions from all segments Operating profit increases 12.6 percent to 4.4 billion euros, with particular strong contribution from the Property-Casualty segment Shareholders’ core net income advances by 12.7 percent and reaches 2.9 billion euros 9M 2025 Continued strong and diversified growth across our businessesand record operating profitTotal business volume rises 8.5 1 percent and reaches 141.2 billion euros with contributions from all segments Operating profit increases 10.4 percent to 13.1 billion euros, our highest nine-month operating profit ever, reaching 82 percent of our full-year outlook midpoint Shareholders’ core net income advances 10.5 percent to 8.4 billion euros. Ad
Galderma Completes Successful Placement of CHF 175 Million Bond14.11.2025 07:00:00 CET | Press release
NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE LAW OR REGULATION. Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced the successful placement of a single-tranche CHF 175 million Swiss franc-denominated bond. The bond has a maturity of 5 years and carries a fixed-rate annual coupon of 0.9425%. Net proceeds from the transaction will be used to partially refinance Galderma’s existing bank term loan issued at its initial public offering (IPO) in March 2024, as well as for general corporate purposes. This marks the company’s third CHF-bond issuance since listing. The new bond will be listed on the SIX Swiss Exchange, with the settlement date expected on December 10, 2025. BNP Paribas and UBS jointly led the transaction. Galderma is rated BBB (stable outlook) by Fitch. The same rating is also expected to be assigned to the new bond. The successful issuance is leverage-ne
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
